Estech develops medical devices that enable less invasive cardiac surgery including coronary artery bypass grafts, valve repair and cardiac tissue ablation.
Acquired by AtriCure, Inc. in 2014.
Acquired by AtriCure, Inc. in 2014.
Total raised: $8.5M
Investors 1
| Date | Name | Website |
| - | Telegraph ... | thpartners... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 07.12.2010 | - | $8.5M | - |
Mentions in press and media 10
| Date | Title | Description |
| 31.01.2014 | AtriCure Completes Acquisition of Estech | WEST CHESTER, Ohio—(BUSINESS WIRE)—Jan. 2, 2014—AtriCure, Inc. (Nasdaq: ATRC), a leading Atrial Fibrillation medical device provider, today announced the completion of the previously announced acquisition of Endoscopic Technologies, Inc. d/... |
| 07.12.2010 | Estech completes $8.5m Equity Financing | Estech, a San Ramon, Calif.-based developer and supplier of a minimally invasive cardiac ablation surgical platform, has completed a $8.5m equity financing. Investors include Saints Capital Everest, Telegraph Hill Partners, NBGI Ventures an... |
| 16.06.2010 | AtriCure stock rises 20 percent on approval news | By Mary Vanac Shares of West Chester, Ohio-based AtriCure Inc. (NASDAQ:ATRC) rose more than 20 percent Tuesday, a day after the Food & Drug Administration approved the company’s AtriClip system for sale in the United States. AtriCure sh... |
| 15.06.2010 | AtriCure: A superhero wearing an underdog’s uniform? | In May, during his company’s first-quarter conference call with analysts, Drachman estimated the U.S. market for the AtriClip Gillinov-Cosgrove Left Atrial Appendage Exclusion System at “approximately 185,000 patients representing a market ... |
| 02.02.2010 | AtriCure to pay $3.8 million to settle Justice Department claims | AtriCure on Tuesday declined to elaborate on the terms of its definitive agreement with the Justice Department, saying the terms are “substantially identical” to those disclosed in November. Then, the company said it had set aside $3.8 mill... |
| 15.07.2009 | Estech pays $1.4M to settle Medicare fraud suit | Endoscopic Technologies, maker of tools for non-invasive heart surgeries that does business as Estech, says it will pay $1.4 million to settle claims that it gave kickbacks to health-care providers that used its devices, reports VentureWire... |
| 03.06.2009 | Estech pumps in $8M for heart surgery tools | Endoscopic Technologies, a company known as Estech that makes devices for minimally-invasive heart surgeries, has tacked $8 million onto an open second round of funding, bringing its total to $19.3 million. The new money will be used to boo... |
| 02.12.2008 | Endoscopic Tech nabs $11M for heart surgery tools | Medical device maker Endoscopic Technologies brought in an $11 million tranche of second-round funding from Boston Scientific, Telegraph Hill Partners and Saints Capital. The money will be used to further develop the San Ramon, Calif. compa... |
| - | AtriCure: A superhero wearing an underdog’s uniform? | Shares of West Chester, Ohio-based AtriCure Inc. (NASDAQ: ATRC) rose more than 20 percent Tuesday, a day after the Food and Drug Administration approved the company’s AtriClip system for sale in the United States. AtriCure shares rose as hi... |
| - | AtriCure to pay $3.8 million to settle Justice Department claims | Updated 6:53 p.m. WEST CHESTER, Ohio — AtriCure Inc. has agreed to pay the federal government $3.76 million to settle claims that it promoted its surgical cardiac ablation devices for unapproved uses, the Justice Department said today in a ... |